期刊
MATURITAS
卷 140, 期 -, 页码 49-54出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.maturitas.2020.06.005
关键词
Pueraria mirifica; Placebo; Genitourinary syndrome of menopause; Vaginal microenvironment
资金
- Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Objective: To compare the effects of a 12-week course of 5%Pueraria mirifica gel and placebo gel on the prevalence of bacterial vaginosis, vaginal fungi, vaginal pH, vaginal health index (VHI), and genitourinary symptoms in postmenopausal women. Study design: In a randomized, double-blinded, placebo-controlled study (TCTR20160517002), 60 post-menopausal women were randomly assigned to a 12-week course of eitherP. mirifica gel or identical placebo gel. Main outcome measure: Vaginal Nugent score, fungal culture, pH, VHI, and genitourinary symptoms were evaluated at baseline and after 12 weeks of treatment. Results: After 12 weeks of treatment, the proportion of participants with an abnormal Nugent score in the P. mirifica and the placebo groups were 6.7 % (2/30) and 23.3 % (7/30), respectively (p = 0.006). The mean changes in Nugent scores and VHI were significantly higher in the P. mirifica group (p < 0.05). There were no significant decreases in the prevalence of symptoms between the two groups after treatment (p > 0.05). Conclusion: A 12-week course of treatment with 5 % P. mirifica vaginal gel in postmenopausal women with GSM has been proved to be effective in reducing indicators of bacterial vaginosis compared with placebo gel. Nevertheless, the effect on alleviating genital symptoms was not demonstrated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据